467 related articles for article (PubMed ID: 2810116)
1. Coupling of subtypes of the muscarinic receptor to adenylate cyclase in the corpus striatum and heart.
Ehlert FJ; Delen FM; Yun SH; Friedman DJ; Self DW
J Pharmacol Exp Ther; 1989 Nov; 251(2):660-71. PubMed ID: 2810116
[TBL] [Abstract][Full Text] [Related]
2. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
Ehlert FJ; Tran LP
J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
[TBL] [Abstract][Full Text] [Related]
3. The interaction of amitriptyline, doxepin, imipramine and their N-methyl quaternary ammonium derivatives with subtypes of muscarinic receptors in brain and heart.
Ehlert FJ; Delen FM; Yun SH; Liem HA
J Pharmacol Exp Ther; 1990 Apr; 253(1):13-9. PubMed ID: 2329499
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
5. Differential coupling of subtypes of the muscarinic receptor to adenylate cyclase and phosphoinositide hydrolysis in the longitudinal muscle of the rat ileum.
Candell LM; Yun SH; Tran LL; Ehlert FJ
Mol Pharmacol; 1990 Nov; 38(5):689-97. PubMed ID: 2172776
[TBL] [Abstract][Full Text] [Related]
6. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
Burke RE
Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
[TBL] [Abstract][Full Text] [Related]
7. A cholinergic antagonist identifies a subclass of muscarinic receptors in isolated rat pancreatic acini.
Korc M; Ackerman MS; Roeske WR
J Pharmacol Exp Ther; 1987 Jan; 240(1):118-22. PubMed ID: 2433426
[TBL] [Abstract][Full Text] [Related]
8. Gallamine allosterically antagonizes muscarinic receptor-mediated inhibition of adenylate cyclase activity in the rat myocardium.
Ehlert FJ
J Pharmacol Exp Ther; 1988 Nov; 247(2):596-602. PubMed ID: 3183955
[TBL] [Abstract][Full Text] [Related]
9. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
Smith TD; Annis SJ; Ehlert FJ; Leslie FM
J Pharmacol Exp Ther; 1991 Mar; 256(3):1173-81. PubMed ID: 2005579
[TBL] [Abstract][Full Text] [Related]
10. Muscarinic receptor binding and muscarinic receptor-mediated inhibition of adenylate cyclase in rat brain myelin.
Larocca JN; Ledeen RW; Dvorkin B; Makman MH
J Neurosci; 1987 Dec; 7(12):3869-76. PubMed ID: 3694257
[TBL] [Abstract][Full Text] [Related]
11. Binding of [3H]AF-DX 384 to cloned and native muscarinic receptors.
Miller JH; Gibson VA; McKinney M
J Pharmacol Exp Ther; 1991 Nov; 259(2):601-7. PubMed ID: 1941609
[TBL] [Abstract][Full Text] [Related]
12. Characterization of muscarinic M4 binding sites in rabbit lung, chicken heart, and NG108-15 cells.
Lazareno S; Buckley NJ; Roberts FF
Mol Pharmacol; 1990 Dec; 38(6):805-15. PubMed ID: 2250662
[TBL] [Abstract][Full Text] [Related]
13. Muscarinic receptor heterogeneity in rat central nervous system. I. Binding of four selective antagonists to three muscarinic receptor subclasses: a comparison with M2 cardiac muscarinic receptors of the C type.
Waelbroeck M; Gillard M; Robberecht P; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):91-9. PubMed ID: 3600616
[TBL] [Abstract][Full Text] [Related]
14. M1 and M3 muscarinic receptor subtypes in rat forebrain.
Pavia J; Marquez E; Laukkonen S; Martos F; Gómez A; Sánchez de la Cuesta F
Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of gallamine on dissociation kinetics of (3H)N-methylscopolamine and (3H)pirenzepine from rat brain muscarinic receptors.
Gillard M; Waelbroeck M; Christophe J
J Recept Res; 1986; 6(1):47-61. PubMed ID: 3754901
[TBL] [Abstract][Full Text] [Related]
16. M2 receptor binding of the selective antagonist AF-DX 384: possible involvement of the common allosteric site.
Tränkle C; Andresen I; Lambrecht G; Mohr K
Mol Pharmacol; 1998 Feb; 53(2):304-12. PubMed ID: 9463489
[TBL] [Abstract][Full Text] [Related]
17. Muscarinic cholinergic receptor subtype on frog esophageal peptic cells: binding and secretion studies.
Dickinson KE; Matsumoto H; Anderson W; Pruitt RE; Uemura N; Hirschowitz BI
J Pharmacol Exp Ther; 1988 Sep; 246(3):879-86. PubMed ID: 2901489
[TBL] [Abstract][Full Text] [Related]
18. On the interaction of gallamine with muscarinic receptor subtypes.
Michel AD; Delmendo RE; Lopez M; Whiting RL
Eur J Pharmacol; 1990 Jul; 182(2):335-45. PubMed ID: 2397745
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
Kenakin T; Boselli C
J Pharmacol Exp Ther; 1989 Sep; 250(3):944-52. PubMed ID: 2778720
[TBL] [Abstract][Full Text] [Related]
20. Heparin, dextran and trypan blue allosterically modulate M2 muscarinic receptor binding properties and interfere with receptor-mediated inhibition of adenylate cyclase.
Gerstin EH; Luong T; Ehlert FJ
J Pharmacol Exp Ther; 1992 Dec; 263(3):910-7. PubMed ID: 1281880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
